Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 3(2)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03322124Phase 3Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Role: lead

NCT03378401Phase 3Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Role: lead

NCT02138552Phase 2Completed

Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo

Role: lead

NCT01434914Phase 4Terminated

Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

Role: lead

All 4 trials loaded